To purchase hard copies of this book, please email:
orders@intechopen.com
By only printing on demand InTech ensures our carbon footprint is kept to a minimum.
The data below shows the environmental impact of printing one single book:
48.77 kg wood
2.62 g CO2
44.28 ml Water
Share this page
Ovarian Cancer - Clinical and Therapeutic Perspectives
Edited by Samir A. Farghaly, ISBN 978-953-307-810-6, Hard cover, 338 pages, Publisher: InTech, Published: February 15, 2012 under CC BY 3.0 license, in subject Obstetrics and Gynecology
DOI: 10.5772/2453
Worldwide, Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined. International leaders in the field address the critical biologic and basic science issues relevant to the disease. The book details the molecular biological aspects of ovarian cancer. It provides molecular biology techniques of understanding this cancer. The techniques are designed to determine tumor genetics, expression, and protein function, and to elucidate the genetic mechanisms by which gene and immunotherapies may be perfected. It provides an analysis of current research into aspects of malignant transformation, growth control, and metastasis. A comprehensive spectrum of topics is covered providing up to date information on scientific discoveries and management considerations.
This book is indexed in:
Book contents
- Chapter 1Ovarian Cancer Incidence: Current and Comprehensive Statistics
- Chapter 2Preventive Strategies in Epithelial Ovarian Cancer
- Chapter 3Screening for Ovarian Cancer in Women
- Chapter 4Borderline and Malignant Surface Epithelial – Stromal Tumors of the Ovary
- Chapter 5Central Nervous System Involvement from Epithelial Ovarian Cancer
- Chapter 6Peripheral Neuropathy in Ovarian Cancer
- Chapter 7Therapeutic Strategies in Ovarian Cancer
- Chapter 8Combined Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for the Treatment of Advanced Ovarian Cancer
- Chapter 9Minimally Invasive Surgical Procedures for Patients with Advanced and Recurrent Ovarian Cancer
- Chapter 10Management of Recurrent or Persistent Ovarian Cancer
- Chapter 11Antiprogestins in Ovarian Cancer
- Chapter 12Intraperitoneal Radionuclide Therapy – Clinical and Pre-Clinical Considerations
- Chapter 13Vitamin K2 as a Chemotherapeutic Agent for Treating Ovarian Cancer
- Chapter 14Second-Line Chemotherapy for Platinum- and Taxane-Resistant Epithelial Ovarian Cancer: Pegylated Liposomal Doxorubicin (PLD), Irinotecan, and Combination Therapies at Lower Doses
- Chapter 15HER2 as a Therapeutic Target in Ovarian Cancer
- Chapter 16Sexuality After Ovarian Cancer Therapy
- Chapter 17Quality of Life of Patients with Ovarian Cancer
